The ongoing preclinical research using Lungpacer’s novel phrenic nerve pacing technology was well represented at the 2019 American Thoracic Society Conference, with three preclinical abstracts presented. The studies were based on preclinical work done on non-injured porcine lungs during 50 hours of mechanical ventilation. The abstracts were:
- Transvenous Pacing May Mitigate Ventilation-Induced Diaphragm Atrophy in All Myofiber Types, Fernandez, K., et al.
- Transvenous Phrenic-Nerve-Stimulated Diaphragm Contraction During Mechanical Ventilation Decreases The Loss of End-Expiratory Lung Volume in Non-Injured Lungs, Rohrs, E., et al.
- Transvenous Phrenic-Nerve-Stimulated Diaphragm Contraction Does Not Increase Lung Inflammation in Non-Injured Porcine Lungs During 50 Hours of Mechanical Ventilation, Rohrs, E., et al.